- Q1 2024 VolitionRX Ltd Earnings Call TranscriptMay 14, 2024$0.75 (-14.53%)Earnings
- Q4 2023 VolitionRX Ltd Earnings Call TranscriptMar 26, 2024$0.7498 (+4.14%)Earnings
- VolitionRX Ltd Data Insights Webinar TranscriptOct 26, 2023
- VolitionRX Ltd at LD Micro Main Event XVI Conference TranscriptOct 04, 2023
- Q2 2023 VolitionRX Ltd Earnings Call TranscriptAug 15, 2023$1.21 (-1.63%)Earnings
- VolitionRX Ltd Capital Market Day TranscriptMay 11, 2023
- Q1 2023 VolitionRX Ltd Earnings Call TranscriptMay 11, 2023$1.89 (-1.05%)Earnings
- Q4 2022 VolitionRX Ltd Earnings Call TranscriptMar 16, 2023$1.72 (+11.69%)Earnings
- VolitionRX Ltd at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- VolitionRX Ltd at Sidoti & Company January Micro-Cap Virtual Conference TranscriptJan 19, 2023
- VolitionRX Ltd at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 VolitionRX Ltd Earnings Call TranscriptNov 15, 2022$1.76 (+6.02%)Earnings
- VolitionRX Ltd at OTC Markets Life Sciences Investor Forum TranscriptSep 15, 2022
- Q2 2022 VolitionRX Ltd Earnings Call TranscriptAug 11, 2022$2.02Earnings
- Q1 2022 VolitionRX Ltd Earnings Call TranscriptMay 12, 2022$2.11 (-9.83%)Earnings
- Q4 2021 VolitionRX Ltd Earnings Call TranscriptMar 31, 2022$3.01 (-7.10%)Earnings
- Q3 2021 VolitionRX Ltd Earnings Call TranscriptNov 11, 2021$3.68 (+2.22%)Earnings
- VolitionRX Ltd at SNN Network Summer Event (Virtual) TranscriptAug 18, 2021
- Q2 2021 VolitionRX Ltd Earnings and Business Update Call TranscriptAug 12, 2021
- Q1 2021 VolitionRX Ltd Earnings Call TranscriptMay 12, 2021$3.16 (+0.96%)Earnings
- Q3 2020 VolitionRX Ltd Earnings Call TranscriptNov 13, 2020$3.46 (+7.45%)Earnings
- VolitionRx Limited Presentation at the Rocky Mountain Microcap Conference VI TranscriptNov 13, 2020
- VolitionRX Ltd To Provide Corporate Update TranscriptOct 14, 2020
- VolitionRX Ltd To Present At GCFF TranscriptSep 10, 2020
- VolitionRX Ltd At SNN Network TranscriptAug 19, 2020
- Q1 2020 VolitionRX Ltd Earnings Call TranscriptMay 08, 2020$4.16 (-0.72%)Earnings
- VolitionRx Ltd. Webcast SNN Network TranscriptApr 29, 2020
- Q4 2019 VolitionRX Ltd Earnings Call TranscriptFeb 21, 2020$4.57 (-8.23%)Earnings
- Q3 2019 VolitionRX Ltd Earnings Call TranscriptNov 13, 2019$5.36 (+3.28%)Earnings
VolitionRX Ltd At SNN Network Transcript
And welcome to the VolitionRx webinar. It is now my pleasure to introduce your host, Scott Powell, Head of Investor Relations and US Chief Financial Officer. Thank you, Mr. Powell, you may begin.
Thank you and welcome everyone to the VolitionRx presentation. Appreciate all of you joining virtually and hopefully all of you can see the Volition slide deck.
I do want to point you to our forward-looking statements. So, I'll be making some forward-looking statements on this virtual presentation and to point to the Safe Harbor Act.
And some highlights here about Volition. We are a diagnostics company. We're developing blood tests primarily to screen for a variety of different cancers. But for those of you who have been following our recent news flow, you'll see that we are also developing a blood test for our first noncancer indication for the coronavirus. And I'll start with that since that particular disease is on most of our minds these days.
So, I'll move to slide 3.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)